Modified Nucleotides
AMP-PNP lithium salt hydrate
Quick view. We supply AMP-PNP lithium salt hydrate as a nonhydrolyzable ATP analog for ATP-dependent enzyme and nucleotide-binding studies. CAS 25612-73-1. Catalog target purity: ≥99%.
Product profile
AMP-PNP lithium salt hydrate is classified as nucleotide or nucleotide analog (Formula C10H17N6O12P3·xLi·yH2O; molecular weight 506.20 (free acid)).
AMP-PNP lithium salt hydrate can support enzyme-substrate, in-vitro transcription, polymerase-screening or analytical-reference studies as appropriate to its phosphate state.
For AMP-PNP lithium salt hydrate, reported solubility: Approximately 50 mg/mL in water; ultrasonic mixing may be required. Storage: Store sealed and dry at -20 °C; use the lot-specific CoA for the recommended hold time.
Names and search terms
Confirmed or normalized name variants
- Adenylyl-imidodiphosphate lithium salt hydrate
- Adenosine 5'-(beta,gamma-imido)triphosphate lithium salt
- AMP-PNP Li
- AMP-PNP
- AMP-P(NH)P
- β,γ-ImidoATP
- Adenyl imidodiphosphate
- Adenylyl Imidodiphosphate
Useful catalog search terms
- CAS 25612-73-1
- Nucleotide or nucleotide analog
- Modified Nucleotides
Physicochemical data
| Purity basis | Research-grade target; the lot-specific CoA reports the release result and analytical method. |
|---|---|
| Counterion | Lithium |
| Supply form | Dry hydrated salt |
| InChI | InChI=1S/C10H17N6O12P3/c11-8-5-9(13-2-12-8)16(3-14-5)10-7(18)6(17)4(27-10)1-26-31(24,25)28-30(22,23)15-29(19,20)21/h2-4,6-7,10,17-18H,1H2,(H,24,25)(H2,11,12,13)(H4,15,19,20,21,22,23)/t4-,6-,7-,10-/m1/s |
| InChIKey | PVKSNHVPLWYQGJ-KQYNXXCUSA-N |
| SMILES | [Li+].[Li+].[Li+].[Li+].[H]O[H].Nc1ncnc2n(cnc12)[C@@H]3O[C@H](COP([O-])(=O)OP([O-])(=O)NP([O-])([O-])=O)[C@@H](O)[C@H]3O |
| Boiling point | 965.5±75.0 °C(Predicted) |
| Density | 2.65±0.1 g/cm3(Predicted) |
| pKa | 1.16±0.50(Predicted) |
| Form | powder |
| Color | white |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical qualification includes identity, salt/counterion, assay basis, water content and enzyme compatibility.
- Related uses include LC-MS/HPLC method development and comparison with native or modified nucleotide controls.
Related products
3'-OMe-GDP Disodium Salt
Modified Nucleotides · CAS: 78771-34-3
BX-INTE-00143'-OMe-GMP
Modified Nucleotides · CAS: 400806-41-9
BX-INTE-00153'-OMe-GMP TEA Salt
Modified Nucleotides · CAS: 860605-85-2
BX-INTE-0021Im-3'-OMe-GMP
Modified Nucleotides · CAS: 1005791-93-4
BX-INTE-0023Im-GDP
Modified Nucleotides · CAS: 1199264-75-9
BX-MN-0025(-)-Emtricitabine Triphosphate Tetrasodium Salt
Modified Nucleotides · CAS: 1188407-46-6
Frequently asked questions
Can the package size for AMP-PNP lithium salt hydrate be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-GSS-0001 and CAS 25612-73-1, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Modified Nucleotides product family and its named chemistry.